TAK-559

· Takeda Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for TAK-559, covering 2012-02-02 to 2012-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus [Phase 3]